Knowledge Leaders Capital’s Biogen BIIB Stock Holding History

Knowledge Leaders Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,883	Closed	-$607K	–	104
2022 Q1	$607K	Hold	2,883	–	–	0.44%	89
2021 Q4	$692K	Buy	2,883 +279	+11%	+$71.7K	0.51%	89
2021 Q3	$737K	Buy	2,604 +31	+1%	+$10.2K	0.6%	73
2021 Q2	$891K	Buy	+2,573	New	+$779K	0.6%	79

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Knowledge Leaders Capital's BIIB Position: Q2 2022 in Review

Knowledge Leaders Capital sold out of Biogen (BIIB) in Q2 2022, closing a stake of 2,883 shares — an estimated $607K sold.

Knowledge Leaders Capital first reported a position in BIIB in Q2 2021 and held it in 4 quarters. The position peaked at $891K in Q2 2021. 927 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.

Knowledge Leaders Capital reported no remaining Biogen position as of Q2 2022 after selling out during the quarter.
Knowledge Leaders Capital sold 2,883 Biogen shares in Q2 2022, an estimated $607K.
Knowledge Leaders Capital first reported a position in Biogen in Q2 2021 and held it in 4 quarters.
Knowledge Leaders Capital's Biogen position peaked at $891K in Q2 2021.
927 funds tracked by Wall St. Rank held Biogen as of Q2 2022.

Based on Knowledge Leaders Capital's 13F filing for Q2 2022, filed 3 Aug 2022.